Psychedelic Stocks

ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round

With ATAI eying a Spring 2021 IPO, it announces a $125 million private equity financing for Series C.

11/23/2020 PSW Editor

Mind Cure Sits With $5 Million Cash And Value-Priced For Investors

Mind Cure Health just cashed up. Mind Cure's share price has recently slid. Buying opportunity.

11/23/2020 Jeff Nielson

PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform

Revive Therapeutics and PharmaTher are teaming up to research the potential of psilocybin as a cancer treatment.

11/20/2020 PSW Editor

Adopt A Small Business, Save Them From Extinction

What's the best "investment advice" that any of us could receive in 2020? Invest in Small Business.

11/20/2020 Jeff Nielson

Mind Cure Announces Closing of Oversubscribed $3.6 Million Offering

Including its new financing, Mind Cure currently has in excess of CAD$5 million in cash.

11/19/2020 PSW Editor

Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health

Field Trip announces a new clinics-based research program, beginning with psychedelic therapies for military veterans.

11/19/2020 PSW Editor

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders

Numinus plans a "compassionate access" clinical trial of psilocybin to treat substance abuse.

11/18/2020 PSW Editor

Delic Corp Commences Trading On CSE

Delic Corp is a Delaware-based psychedelics company that has gone public via RTO.

11/18/2020 PSW Editor

Psychedelic Drug Therapy: Cure Your Mind, Save Your Heart?

Will psychedelic drug therapies (simultaneously) save lives as they cure mental health disorders?

11/18/2020 Jeff Nielson

Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program

Field Trip is entering the (already legal) Netherlands psilocybin market with a "Field Trip Health Center" in Amsterdam.

11/17/2020 PSW Editor

Mydecine Innovations Group Offers Management and Clinical Trials Update

Mydecine provides an update on its Phase 2A clinical trial of psilocybin-assisted psychotherapy for the treatment of PTSD.

11/17/2020 PSW Editor

Mind Cure Science Advisor Becomes First CSO As It Builds World-Class Team

Mind Cure's new CSO is a decorated researcher, entrepreneur and inventor.

11/17/2020 PSW Editor